The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Meixin Yu
Ruxin Wang
Ling Pei
Xiaofang Zhang
Jinjing Wei
Yun Wen
Han Liu
Haowen Ye
Jinghao Wang
Lihong Wang
机构：
[1] The First Affiliated Hospital of Jinan University,Department of Endocrinology and Metabolism
[2] The First Affiliated Hospital of Jinan University,Clinical Experimental Center
[3] The First Affiliated Hospital of Jinan University,Department of Pharmacy
[4] Jinan University,The Guangzhou Key Laboratory of Basic and Translational Research on Chronic Diseases, The First Affiliated Hospital
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
GLP-1RA; Diabetes mellitus, type 2; Respiratory illness; Randomized controlled trial; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Acute pancreatitis associated with GLP-1 Agonists (Exenatide and Liraglutide) exposure: a meta-analysis of published randomized controlled clinical trials
    Alves, Carlos
    Batel-Marques, Francisco
    PHARMACOTHERAPY, 2012, 32 (05): : E113 - E113
  • [22] A meta-analysis of the incidence of acne vulgaris in patients treated with GLP-1 agonists
    Ogunremi, Oluwafunke O.
    Ismail, Sana F.
    Dhami, Ramneek K.
    Newton, Jazmin S.
    Kindle, Scott A.
    Kozmenko, Valeriy
    INTERNATIONAL JOURNAL OF WOMENS DERMATOLOGY, 2024, 10 (02):
  • [23] Suicide and Self-Harm with GLP-1 Receptor Agonists: A MetaAnalysis of Randomized Controlled Trials
    Hosseini, Kaveh
    Ebrahimi, Pouya
    Batlle, Juan
    Maqsood, Muhammad Haisum
    Ayati, Aryan
    Long, Clarine
    McGowan, Natalie
    Tarabanis, Constantine
    Laynor, Gregory
    Heffron, Sean
    CIRCULATION, 2024, 150
  • [24] Effect of survodutide, a glucagon and GLP-1 receptor dual agonist, on weight loss: a meta-analysis of randomized controlled trials
    Wan, Haijun
    Xu, Nuo
    Wang, Lijuan
    Liu, Yaping
    Fatahi, Somaye
    Sohouli, Mohammad Hassan
    Guimaraes, Nathalia Sernizon
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [25] The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis
    Chen, Xinda
    Zhao, Peiyi
    Wang, Weihao
    Guo, Lixin
    Pan, Qi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 32 (01): : 117 - 127
  • [26] GLP-1 receptor agonists for Parkinson's disease: An updated meta-analysis
    de Albuquerque, Matheus Barros
    Nunes, Luiz Eduardo Duarte Borges
    Maldonado, Joao Victor de Oliveira
    Ferreira, Diogo Grassano Melo
    Margato, Mateus Macedo
    Rabelo, Lucio Vilar
    Valenca, Marcelo Moraes
    Cordeiro, Lucia Helena Oliveira
    PARKINSONISM & RELATED DISORDERS, 2025, 130
  • [27] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Qian Zhou
    Xingxing Lei
    Shunlian Fu
    Pan Liu
    Cong Long
    Yanmei Wang
    Zinan Li
    Qian Xie
    Qiu Chen
    Diabetology & Metabolic Syndrome, 15
  • [28] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhou, Qian
    Lei, Xingxing
    Fu, Shunlian
    Liu, Pan
    Long, Cong
    Wang, Yanmei
    Li, Zinan
    Xie, Qian
    Chen, Qiu
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [29] Potential Use of GLP-1 and GIP/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?
    Janic, Miodrag
    Skrgat, Sabina
    Harlander, Matevz
    Lunder, Mojca
    Janez, Andrej
    Pantea Stoian, Anca
    El-Tanani, Mohamed
    Maggio, Viviana
    Rizzo, Manfredi
    MEDICINA-LITHUANIA, 2024, 60 (12):
  • [30] Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
    Yasmin Luz Lima de Mesquita
    Izabela Pera Calvi
    Isabela Reis Marques
    Sara Almeida Cruz
    Eduardo Messias Hirano Padrao
    Pedro Emanuel de Paula Carvalho
    Caroliny Hellen Azevedo da Silva
    Rhanderson Cardoso
    Filipe Azevedo Moura
    Vladimir Vitalievich Rafalskiy
    International Journal of Obesity, 2023, 47 : 883 - 892
12345